Found 713 clinical trials
Cognitive Rehabilitation in Schizophrenia and Depression
Schizophrenia and depression are among the most disabling disorders in all of medicine. Cognitive deficits play a key role in patients' disability, affecting their capacity to contribute
- 16 views
- 01 Mar, 2022
- 1 location
Vortioxetine for Post-COVID-19 Condition
A randomized, double-blinded, placebo-controlled trial will be conducted to evaluate vortioxetine, an antidepressant with established pro-cognitive properties, for the treatment of cognitive
- 0 views
- 24 Jul, 2022
- 1 location
A Neurofeedback Intervention to Improve Working Memory in Schizophrenia
Schizophrenia affects 2.4 million Americans and causes significant individual and societal costs. Cognitive deficits including poor working memory arise early in the course of illness, account
- 127 views
- 25 Apr, 2022
- 1 location
Monotherapy of an NMDA Enhancer for Schizophrenia
Previous studies found that some NMDA-enhancing agent was able to augment antioxidant activity and its adjunctive therapy was better than placebo in reducing clinical symptoms and cognitive
- 0 views
- 16 Feb, 2021
- 1 location
Cognitive Training in Survivors of Covid-19: A Randomized Trial
illness is not surprising and perhaps even expected. However, significant cognitive deficits appear to be common even among individuals testing positive for Covid-19 who were never hospitalized. Questions
- 0 views
- 29 Dec, 2021
- 1 location
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
Overlap Syndrome (OVS), is a complex chronic medical condition associated with grave consequences. OVS is highly prevalent in Veterans. Veterans with OVS may be at increased risk for cognitive deficits
- 0 views
- 24 Mar, 2022
- 1 location
Cerebral Impact of Cognitive Remediation for People Suffering From Schizophrenia
Neurocognitive deficits are frequent with people suffering from schizophrenia. Unlike positive symptoms, cognitive deficits are not reduced with antipsychotic medication. They can be very
- 0 views
- 23 Jan, 2021
- 2 locations
Assessing the Role of Cariprazine in Improving Cognition in Euthymic Bipolar Patients (CARPZ-01)
mania) despite remission of mood symptoms. Cognitive deficits (significant cognitive impairments) in bipolar disorder are associated with impairments in everyday functioning and quality of life. Thus
- 0 views
- 10 May, 2022
- 2 locations
Neurofeedback to Improve Working Memory in Mild Cognitive Impairment
rate at which people may convert from MCI to AD. Increasing evidence suggests that abnormal activity in frontal regions of the brain is associated with cognitive deficits observed in AD. Furthermore
- 0 views
- 14 Mar, 2022
- 1 location
Use of Cognitive Stimulation Software for Patients Over the Age of 70 Followed for Breast Cancer: COG-TAB-AGE Feasibility Study
still have little data concerning the management of cognitive disorders induced by oncology treatments, particularly in the elderly patient. It is therefore necessary to offer care adapted to this
- 0 views
- 17 Dec, 2021
- 2 locations